Time Warner Cable Inc.'s (NYSE:TWC) CEO Glenn Britt told the Goldman Sachs Communacopia Conference today that the cable TV operator is seeing a small increase in bad debt from subscribers in subprime housing areas. This was noted as a "little uptick" from customers who could not pay their bill in markets populated with subprime home loans.
The funny thing is that is this is historically a counter-trend. When times get tough, people may cut down on going out to eat or spending in other areas, but cable has traditionally been a good recession-proof business because families stay home more. Obviously, with the Triple Play scoring larger wins, this makes for higher subscriber prices and that might explain part of it.
The company signaled that it would not be increasing discounts for triple play in subprime ridden areas in an effort to retain subscribers. Britt also noted the cable company is interested in making strategic acquisitions where it can, although not on an overly aggressive basis.
Comcast Corp. (NASDAQ:CMCSA) will have its COO presenting at the same conference at 2:50 PM EST today, so it will be interesting to see if they have the same reports. It's hard to imaging they would be immune.
Supposedly one of the economic issues that Ben Bernanke investigates is what is going on with cable bills.
Jon C. Ogg is a partner in 24/7 Wall St., LLC; he does not own securities in the companies he covers.
Last updated: February 13, 2012: 11:06 AM
Hot Stocks
DailyFinance Headlines
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- Diebold FY11 free cash flow exceeded guidance by more than $10M
- Applied Materials March volatility flat into Q1 and sales outlook
- Rumor: Dendreon active on speculation it canceled a conference presentation
- President Obama to discuss FY2013 budget proposal
- Diebold expects the same quarterly seasonality in FY12 as last years'
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Retail Stocks Are for Suckers: Why Their Rally Won't Last
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

